Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results

. 2025 Mar 28 ; 27 (4) : .

Jazyk angličtina Země Velká Británie, Anglie Médium print

Typ dokumentu klinické zkoušky, časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid40163671

Grantová podpora
Abbott
Investigator Grant Fellowships
National Health and Medical Research Council of Australia

AIMS: Pulsed field ablation (PFA) is a growing ablation modality for pulmonary vein isolation (PVI) in atrial fibrillation (AF) patients. This study assesses the 6-month safety and effectiveness of a novel balloon-in-basket, mapping-integrated PFA system, with a purpose-built form factor for PVI. METHODS AND RESULTS: The VOLT CE Mark Study is a prospective, multi-center, pre-market study. A total of 150 patients with drug-refractory paroxysmal (PAF) or persistent AF (PersAF) were enrolled between 8 November 2023 and 14 March 2024, of which 146 patients (age 64.1 ± 10.0 years, 63.0% male, 70.5% PAF) underwent PVI with the balloon-in-basket PFA catheter and system featuring integrated electroanatomic mapping with contact-sensing. Study endpoints were the rate of primary serious adverse events within 7 days as well as acute procedural effectiveness and 6-month freedom from recurrence. Acute effectiveness was achieved in 99.1% (573/578) of treated PVs (98.6% of patients, 144/146) with 17.6 ± 5.7 PFA applications/patient. Procedure, fluoroscopy, LA dwell, and transpired ablation times were 100.4 ± 33.0, 17.3 ± 12.1, 39.4 ± 20.6, and 31.4 ± 16.8 min, respectively. There were 4 (2.7%; 4/146) primary serious adverse events. The rate of freedom from documented atrial arrhythmias was 88.2% in PAF patients and 76.7% in PersAF patients (freedom from symptomatic recurrence was documented in 90.2% of PAF patients and 74.4% of PersAF patients) through 6-months post-index procedure. CONCLUSION: The VOLT CE Mark Study primary results demonstrate the safety and effectiveness of the novel balloon-in-basket PFA system to perform PVI in PAF and PersAF.

Cardiology Department Nemocnice Na Homolce Roentgenova 37 150 00 Praha 5 Czechia

Centre for Heart Rhythm Disorders University of Adelaide and Royal Adelaide Hospital Port Rd Adelaide SA 5000 Australia

Department of Cardiology and Intensive Care Medicine Asklepios Hospital St Georg Hamburg Germany

Department of Cardiology AZ Sint Jan Ruddershove 10 8000 Brugge Belgium

Department of Cardiology The Prince Charles Hospital 627 Rode Rd Chermside QLD 4032 Australia

Department of Cardiology UMC Utrecht Heidelberglaan 100 Utrecht 3584 CX Netherlands

Department of Cardiology University of Melbourne Royal Melbourne Hospital City Campus 300 Grattan Street Parkville Victoria 3050 Australia

Department of Cardiology Victorian Heart Hospital Monash Health 246 Clayton Road Clayton Victoria 3168 Australia

Department of Internal Medicine 2 with Cardiology Angiology and Intensive Care Medicine Ordensklinikum Linz Elisabethinen Linz Austria

Department of Rhythmology University Heart Center University Hospital Schleswig Holstein Lübeck Germany

Division of Cardiac Arrhythmias and Electrophysiology Cardiology Department Hospital Universitari i Politecnic La Fe Avinguda de Fernando Abril Martorell 106 Quatre Carreres 46026 València Valencia Spain

Electrophysiology Abbott Minneapolis MN USA

German Center for Cardiovascular Research Partner Site Hamburg Kiel Lübeck Lübeck Germany

Heart Rhythm Management Center UZ Brussels Vrij Universiteit Brussel Brussels Belgium

Kansas City Heart Rhythm Institute and Research Foundation 5100 W 100th St Suite 200 Overland Park KS 66211 USA

Mount Sinai Fuster Heart Hospital One Gustave L Levy Medical Place New York New York 10029 USA

Komentář v

PubMed

Zobrazit více v PubMed

Tzeis  S, Gerstenfeld  EP, Kalman  J, Saad  EB, Sepehri Shamloo  A, Andrade  JG  et al.  2024 European heart rhythm association/heart rhythm society/Asia Pacific heart rhythm society/Latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace  2024;26:1–107.

Chun  K-RJ, Schmidt  B, Metzner  A, Tilz  R, Zerm  T, Köster  I  et al.  The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J  2008;30:699–709. PubMed PMC

Leitz  P, Mönnig  G, Güner  F, Dechering  DG, Wasmer  K, Reinke  F  et al.  Comparing learning curves of two established “single-shot” devices for ablation of atrial fibrillation. J Interv Card Electrophysiol  2018;53:317–22. PubMed

Heeger  CH, Sohns  C, Pott  A, Metzner  A, Inaba  O, Straube  F  et al.  Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: results of the worldwide YETI registry. Circ Arrhythm Electrophysiol  2022;15:e010516. PubMed PMC

Tilz  RR, Schmidt  V, Pürerfellner  H, Maury  P, Chun  K, Martinek  M  et al.  A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J  2023;44:2458–69. PubMed PMC

Chun  K-RJ, Miklavcic  D, Vlachos  K, Bordignon  S, Scherr  D, Jais  P  et al.  State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective. Europace  2024;26:1–14. PubMed PMC

Ekanem  E, Neuzil  P, Reichlin  T, Kautzner  J, van der Voort  P, Jais  P  et al.  Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17 K study. Nat Med  2024;30:2020–9. PubMed PMC

Schmidt  B, Bordignon  S, Neven  K, Reichlin  T, Blaauw  Y, Hansen  J  et al.  EUropean real-world outcomes with pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace  2023;25:1–11. PubMed PMC

Boersma  L, Andrade  JG, Betts  T, Duytschaever  M, Pürerfellner  H, Santoro  F  et al.  Progress in atrial fibrillation ablation during 25 years of europace journal. Europace  2023;25:1–14. PubMed PMC

Scherr  D, Turagam  MK, Maury  P, Blaauw  Y, van der Voort  P, Neuzil  P  et al.  Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study. Europace  2025:euaf012. PubMed

Sanders  P, Healy  S, Emami  M, Kotschet  E, Miller  A, Kalman  JM. Initial clinical experience with the balloon-in-basket pulsed field ablation system: acute results of the VOLT CE mark feasibility study. Europace  2024;26:1–10. PubMed PMC

Popa  MA, Venier  S, Menè  R, Della Rocca  DG, Sacher  F, Derval  N  et al.  Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis. Circ Arrhythm Electrophysiol  2024;17:e012732. PubMed

Mercado Montoya  M, Gomez Bustamante  T, Jessen  M, Kulstad  E, Mickelsen  S, Overzet  L. Quantification of hemolysis rates from pulsed field ablation. Eur Heart J  2024;45:ehae666.387.

Garg  J, Chaudhary  R, Palaniswamy  C, Shah  N, Krishnamoorthy  P, Bozorgnia  B  et al.  Cryoballoon versus radiofrequency ablation for atrial fibrillation: a meta-analysis of 16 clinical trials. J Atr Fibrillation  2016;9:1429. PubMed PMC

Van Belle  Y, Janse  P, Rivero-Ayerza  MJ, Thornton  AS, Jessurun  ER, Theuns  D  et al.  Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J  2007;28:2231–7. PubMed

Reddy  VY, Gerstenfeld  EP, Natale  A, Whang  W, Cuoco  FA, Patel  C  et al.  Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med  2023;389:1660–71. PubMed

Vetta  G, Della Rocca  DG, Parlavecchio  A, Magnocavallo  M, Sorgente  A, Pannone  L  et al.  Multielectrode catheter-based pulsed electric field vs. Cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis. Europace  2024;26:1–12. PubMed PMC

Reddy  VY, Calkins  H, Mansour  M, Wazni  O, Di Biase  L, Bahu  M  et al.  Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial. Circulation  2024;150:1174–86. PubMed PMC

Saleemi  S, Dashwood  A, Kader  Z, Bi  A, Ky  V, Young  J  et al.  Pulsed field ablation (PFA) for atrial fibrillation: an analysis of immediate procedural outcomes and early discharge in 210 patients—insights from a single centre experience. Heart Lung Circ  2024;33:S442.

Verma  A, Haines  DE, Boersma  LV, Sood  N, Natale  A, Marchlinski  FE  et al.  Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation  2023;147:1422–32. PubMed PMC

Reddy  VY, Peichl  P, Anter  E, Rackauskas  G, Petru  J, Funasako  M  et al.  A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol  2023;9:1786–801. PubMed

Turagam  MK, Neuzil  P, Schmidt  B, Reichlin  T, Neven  K, Metzner  A  et al.  Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation  2023;148:35–46. PubMed

Ruwald  MH, Haugdal  M, Worck  R, Johannessen  A, Hansen  ML, Sørensen  SK  et al.  Characterization of durability and reconnection patterns at time of repeat ablation after single-shot pulsed field pulmonary vein isolation. J Interv Card Electrophysiol  2024;67:379–87. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...